AZZ Inc. (AZZ) Guidance & Earnings Results

On 2026-10-13 AZZ Inc. raised guidance: "FY2027 sales raised to $1.825-$1.875B from $1.80-$1.85B; Adjusted EBITDA raised to $380-$420M from $375-$415M; Adjusted diluted EPS raised to $7.00-$7.30 from $6.75-$7.15; capex expected $80-$100M; interest expense…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

AZZAZZ Inc.Follow AZZ — free

Specialty Business Services · Industrials

—

Price chart with a free account

Market cap: 4.0B
P/E TTM: 23.8
Dividend yield: 0.6%
52-week: —
Next earnings: 5 Jan, in 72 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
13 Oct 26	Raised	FY2027 sales raised to $1.825-$1.875B from $1.80-$1.85B; Adjusted EBITDA raised to $380-$420M from $375-$415M; Adjusted diluted EPS raised to $7.00-$7.30 from $6.75-$7.15; capex expected $80-$100M; interest expense $35-$45M; debt reduction $100-$140M; effective tax rate 25%. · full year
8 Jul 26	Raised	FY2027 sales raised to $1.80-1.85B from $1.725-1.775B; Adjusted EBITDA raised to $375-415M from $360-400M; Adjusted Diluted EPS raised to $6.75-7.15 from $6.50-7.00; FY2027 capex ~$80-100M · full year
7 Jan 26	Raised	FY2026 Sales $1.625-$1.7B, Adj. EBITDA $360-$380M, Adj. EPS $5.90-$6.20 · full year
8 Oct 25	Reaffirmed	Sales $1.625-$1.725B, Adjusted EBITDA $360-$400M, Adjusted Diluted EPS $5.75-$6.25 · full year

AZZ Inc. — questions

What guidance did AZZ Inc. give?: On 2026-10-13: "FY2027 sales raised to $1.825-$1.875B from $1.80-$1.85B; Adjusted EBITDA raised to $380-$420M from $375-$415M; Adjusted diluted EPS raised to $7.00-$7.30 from $6.75-$7.15; capex expected $80-$100M; interest expense $35-$45M; debt reduction $100-$140M; effective tax rate 25%."
When does AZZ Inc. report earnings?: AZZ Inc.'s next earnings report is expected on 2027-01-05.

Every figure on this page comes from AZZ Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.